Search Results

There are 13235 results for: content related to: Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia

  1. Therapy of Advanced-Stage and Resistant Chronic Myeloid Leukemia

    Leukemias: Principles and Practice of Therapy

    Devendra K. Hiwase, Timothy P. Hughes, Pages: 281–295, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch23

  2. Chronic Myelogenous Leukemia

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt008

  3. You have free access to this content
    ASH 2009 meeting report—Top 10 clinically oriented abstracts in acute leukemia

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 277–280, Amber Fullmer, Jorge Cortes, Hagop Kantarjian and Elias Jabbour

    Version of Record online : 13 JAN 2010, DOI: 10.1002/ajh.21644

  4. You have free access to this content
    Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

    Cancer

    Volume 98, Issue 3, 1 August 2003, Pages: 522–528, Hagop M. Kantarjian, Susan O'Brien, Jorge Cortes, Francis J. Giles, Stefan Faderl, Jean-Pierre Issa, Guillermo Garcia-Manero, Mary Beth Rios, Jianqin Shan, Michael Andreeff, Michael Keating and Moshe Talpaz

    Version of Record online : 13 JUN 2003, DOI: 10.1002/cncr.11543

  5. You have free access to this content
    Detection of hereditary hemochromatosis and biochemical iron overload in primary care: A multicenter case finding study in Spain

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 294–296, Núria Freixenet, Maria Sierra Moreno-Rosel, Maria Jesús Barceló, Antonia Serrano, Marina Payà, Lourdes Crespo, Maria José Pérez-Lucena, Albert Altés, Montserrat Baiget and Jordi Félez

    Version of Record online : 8 JAN 2010, DOI: 10.1002/ajh.21634

  6. You have free access to this content
    ASH 2009 meeting report—Top 10 clinically oriented abstracts in lymphoma

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 280–283, Thomas M. Habermann

    Version of Record online : 13 JAN 2010, DOI: 10.1002/ajh.21645

  7. You have free access to this content
    Is the JAK2V617F mutation detectable in healthy volunteers?

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 287–288, Christophe Martinaud, Patrick Brisou and Marie-Joelle Mozziconacci

    Version of Record online : 23 DEC 2009, DOI: 10.1002/ajh.21627

  8. You have free access to this content
    ASH 2009 meeting report—Top 10 clinically oriented abstracts in chronic myeloid leukemia

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 283–286, Amber Fullmer, Jorge Cortes, Hagop Kantarjian and Elias Jabbour

    Version of Record online : 27 JAN 2010, DOI: 10.1002/ajh.21662

  9. You have free access to this content
    Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 288–290, Ali T. Taher, Khaled M. Musallam, John C. Wood and Maria Domenica Cappellini

    Version of Record online : 23 DEC 2009, DOI: 10.1002/ajh.21626

  10. You have free access to this content
    Cardiac tamponade or hemopericardium are not associated with bleeding risk factors in consecutive patients hospitalized with noniatrogenic, pericardial effusions

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 300–301, Bryan A. Faller, Qin Zhang and Joel Picus

    Version of Record online : 13 JAN 2010, DOI: 10.1002/ajh.21643

  11. You have free access to this content
    Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review

    European Journal of Haematology

    Volume 87, Issue 5, November 2011, Pages: 381–393, Shantashri Vaidya, Kanjaksha Ghosh and Babu Rao Vundinti

    Version of Record online : 2 OCT 2011, DOI: 10.1111/j.1600-0609.2011.01689.x

  12. You have free access to this content
    Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 290–293, Fernando Silva, José A. Pérez-Simón, Teresa Caballero Velazquez, Cristina Encinas, Fermín M. Sánchez-Guijo, María Díez-Campelo, Enrique Colado, Jesús Martín, Fernanda Villanueva-Gomez, Lourdes Vazquez, Consuelo del Cañizo, Dolores Caballero and Jesús San Miguel

    Version of Record online : 31 DEC 2009, DOI: 10.1002/ajh.21613

  13. You have free access to this content
    Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission

    American Journal of Hematology

    Volume 85, Issue 4, April 2010, Pages: 296–299, Jan Václavík, Tomáš Szotkowski, Martin Hutyra, Jiří Kozák, Jan Lukl and Miloš Táborský

    Version of Record online : 8 JAN 2010, DOI: 10.1002/ajh.21635

  14. Current and Future Clinical Strategies in the Management of Chronic Myeloid Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 9P2, September 2010, Pages: 77S–101S, Kamakshi V. Rao, Andrea Iannucci and Elias Jabbour

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.30.pt2.77S

  15. You have free access to this content
    Evolution of decitabine development

    Cancer

    Volume 112, Issue 11, 1 June 2008, Pages: 2341–2351, Elias Jabbour, Jean-Pierre Issa, Guillermo Garcia-Manero and Hagop Kantarjian

    Version of Record online : 8 APR 2008, DOI: 10.1002/cncr.23463

  16. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  17. You have free access to this content
    Current and emerging treatment options in chronic myeloid leukemia

    Cancer

    Volume 109, Issue 11, 1 June 2007, Pages: 2171–2181, Elias Jabbour, Jorge E. Cortes, Francis J. Giles, Susan O'Brien and Hagop M. Kantarjian

    Version of Record online : 12 APR 2007, DOI: 10.1002/cncr.22661

  18. Pharmacogenomics of Dasatinib (Sprycel™)

    Kinase Inhibitor Drugs

    Fei Huang, Edwin A. Clark, Pages: 365–402, 2009

    Published Online : 28 SEP 2009, DOI: 10.1002/9780470524961.ch15

  19. You have free access to this content
    Chronic myelogenous leukemia: A review and update of therapeutic strategies

    Cancer

    Volume 98, Issue 3, 1 August 2003, Pages: 437–457, Guillermo Garcia-Manero, Stefan Faderl, Susan O'Brien, Jorge Cortes, Moshe Talpaz and Hagop M. Kantarjian

    Version of Record online : 4 JUN 2003, DOI: 10.1002/cncr.11520

  20. You have free access to this content
    Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring

    American Journal of Hematology

    Volume 91, Issue 2, February 2016, Pages: 252–265, Elias Jabbour and Hagop Kantarjian

    Version of Record online : 22 JAN 2016, DOI: 10.1002/ajh.24275